Related Experiment Videos

Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients

Florian Kronenberg1, Arno Lingenhel, Ulrich Neyer

  • 1Institute of Medical Biology and Human Genetics, University of Innsbruck, Innsbruck, Austria. Florian.Kronenberg@uibk.ac.at

Kidney International. Supplement
|April 16, 2003
PubMed

Insights

Dialysis patients have prevalent dyslipidemic factors, increasing cardiovascular risk. Continuous ambulatory peritoneal dialysis (CAPD) patients show worse lipid profiles and more concurrent risk factors than hemodialysis (HD) patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Chemistry

Background:

  • Dyslipidemia significantly contributes to cardiovascular risk in patients undergoing dialysis.
  • This risk is often underestimated, necessitating a thorough evaluation of lipid profiles in these populations.

Purpose of the Study:

  • To determine the prevalence of dyslipidemic factors in a large cohort of hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) patients.
  • To compare the lipid profiles and frequency of dyslipidemic factors between HD and CAPD patient groups.

Main Methods:

  • Utilized Medical Experts Group recommendations for categorizing dyslipidemic factors: total cholesterol >200 mg/dL, LDL cholesterol >100 mg/dL, HDL cholesterol <40 mg/dL, triglycerides >180 mg/dL, and Lp(a) >30 mg/dL.
  • Assessed lipid profiles in 564 HD patients and 168 CAPD patients.

Main Results:

  • CAPD patients exhibited a significantly worse lipid profile compared to HD patients, with higher rates of elevated total cholesterol (67% vs. 34%), triglycerides (47% vs. 28%), and Lp(a) (37% vs. 30%).
  • Approximately two-thirds of patients in both groups had elevated LDL cholesterol and low HDL cholesterol.
  • CAPD patients more frequently presented with three or four concurrent dyslipidemic factors (P < 0.001).
  • Apolipoprotein A-IV levels were elevated in both patient groups compared to controls (P < 0.001).

Conclusions:

  • Dyslipidemic risk factors are highly prevalent in patients undergoing dialysis.
  • The co-occurrence of multiple dyslipidemic factors is more common in CAPD patients than in HD patients, highlighting a critical need for targeted cardiovascular risk management in this population.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...